T1	Participants 130 195	acute exacerbated chronic obstructive pulmonary disease patients]
T2	Participants 372 444	acute exacerbated chronic obstructive pulmonary disease (COPD) patients.
T3	Participants 453 502	Seventy-nine patients with acute exacerbated COPD
T4	Participants 2003 2035	acute exacerbated COPD patients.
